Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eye

Current Eye Research

Volumn 36, Issue 2, 2011, Pages 94-102

  Hesje, Christine K ^a   Sanfilippo, Christine M ^a   Haas, Wolfgang ^a   Morris, Timothy W ^a  

^a BAUSCH AND LOMB   (United States)

Author keywords

Bacterial infection; Community acquired MRSA; Multi drug resistance; spa typing; Staphylococcal virulence factors

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; BESIFLOXACIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DNA SEQUENCE; EYE INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; BACTERIAL TYPING TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; EXOTOXINS; EYE INFECTIONS, BACTERIAL; GENOTYPE; HUMANS; LEUKOCIDINS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 79551508568     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.534229     Document Type: Article

References (48)

1. Miller D, Diaz MG, Perez EM, et al. Prevalence of community acquired methicillin resistant Staphylococcus aureus among ocular MRSA isolates. Am J Infect Control. 2006;34:E23-E24.
2. Jevons MP. 'Celbenin'-resistant staphylococci. Br Med J. 1961;1:124-125.
3. Deresinski S. Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis. 2005;40:562-573.
4. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178-182.
5. Warshawsky B, Hussain Z, Gregson DB, et al. Hospitaland community-based surveillance of methicillin-resistant Staphylococcus aureus: Previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol. 2000;21:724-727.
6. Monnet DL, MacKenzie FM, Lopez-Lozano JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis. 2004;10:1432-1441.
7. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593-598.
8. Boyce JM. Community-associated methicillin-resistant Staphylococcus aureus as a cause of health care-associated infection. Clin Infect Dis. 2008;46:795-798.
9. Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 2006;42:647-656.
10. Popovich KJ, Weinstein RA, Hota B. Are community- associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46:787-794.
11. Fowler Jr., VG, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med. 2003;163:2066-2072.
12. King MD, Humphrey BJ, Wang YF, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med. 2006;144: 309-317.
13. Rutar T, Chambers HF, Crawford JB, et al. Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006;113:1455-1462.
14. Tsuji BT, Rybak MJ, Cheung CM, et al. Community- and health care-associated methicillin-resistant Staphylococcus aureus: A comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis. 2007;58:41-47.
15. Chen L, Mediavilla JR, Oliveira DC, et al. Multiplex realtime PCR for rapid staphylococcal cassette chromosome mec typing. J Clin Microbiol. 2009;47:3692-3706.
16. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44:1549-1555.
17. Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol. 2008;8:747-763.
18. Zhang K, McClure JA, Elsayed S, et al. Novel staphylococcal cassette chromosome mec type carrying class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53:531-540.
19. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-1827.
20. Kilic A, Li H, Stratton CW, et al. Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee. J Clin Microbiol. 2006;44:4436-4440.
21. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin- resistant Staphylococcus aureus infection. JAMA. 2003;290:2976-2984.
22. Vandenesch F, Naimi T, Enright MC, et al. Communityacquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis. 2003;9:978-984.
23. Lo WT, Lin WJ, Tseng MH, et al. Risk factors and molecular analysis of Panton-Valentine leukocidin-positive methicillin- resistant Staphylococcus aureus colonization in healthy children. Pediatr Infect Dis J. 2008;27:713-718.
24. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-1132.
25. Etienne M, Croisier D, Charles PE, et al. Effect of low-level resistance on subsequent enrichment of fluoroquinoloneresistant Streptococcus pneumoniae in rabbits. J Infect Dis. 2004;190:1472-1475.
26. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated methicillin-resistant Staphylococcus aureus. Lancet. 2010;375:1557-1568.
27. Mellmann A, Weniger T, Berssenbrugge C, et al. Characterization of clonal relatedness among the natural population of Staphylococcus aureus strains by using spa sequence typing and the BURP (based upon repeat patterns) algorithm. J Clin Microbiol. 2008;46:2805-2808.
28. Harmsen D, Claus H, Witte W, et al. Typing of methicillin- resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41:5442-5448.
29. Hallin M, Deplano A, Denis O, et al. Validation of pulsedfield gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections. J Clin Microbiol. 2007;45:127-133.
30. Koreen L, Ramaswamy SV, Graviss EA, et al. spa typing method for discriminating among Staphylococcus aureus isolates: Implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol. 2004;42:792-799.
31. Mellmann A, Weniger T, Berssenbrugge C, et al. Based Upon Repeat Pattern (BURP): An algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms. BMC Microbiol. 2007; 7:98.
32. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, Eighth Edition. CLSI document M7-A8. Wayne, PA: CLSI; 2009.
33. Larsen AR, Stegger M, Sorum M. spa typing directly from a mecA, spa and pvl multiplex PCR assay-A cost- effective improvement for methicillin-resistant Staphylococcus aureus surveillance. Clin Microbiol Infect. 2008;14: 611-614.
34. Zhang K, Sparling J, Chow BL, et al. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol. 2004;42:4947-4955.
35. Zhang K, McClure JA, Elsayed S, et al. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 2005;43:5026-5033.
36. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth Informational Supplement. CLSI document M100-S20. Wayne, PA: CLSI; 2010.
37. Francis JS, Doherty MC, Lopatin U, et al. Severe community- onset pneumonia in healthy adults caused by methicillin- resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis. 2005;40:100-107.
38. Kluytmans-Vandenbergh MF, Kluytmans JA. Communityacquired methicillin-resistant Staphylococcus aureus: Current perspectives. Clin Microbiol Infect. 2006;12:9-15.
39. Deurenberg RH, Vink C, Kalenic S, et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2007;13:222-235.
40. Limbago B, Fosheim GE, Schoonover V, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: A population-based analysis. J Clin Microbiol. 2009;47:1344-1351.
41. Diep BA, Carleton HA, Chang RF, et al. Roles of 34 virulence genes in the evolution of hospital- and community- associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006;193:1495-1503.
42. Fenner L, Widmer AF, Dangel M, et al. Distribution of spa types among methicillin-resistant Staphylococcus aureus isolates during a 6-year period at a low-prevalence university hospital. J Med Microbiol. 2008;57:612-616.
43. Grundmann H, Aanensen DM, van den Wijngaard CC, et al. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: A molecular-epidemiological analysis. PLoS Med. 2010;7:e1000215.
44. Witte W, Strommenger B, Cuny C, et al. Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006. J Antimicrob Chemother. 2007;60:1258-1263.
45. Chlebowicz MA, Nganou K, Kozytska S, et al. Recombination between ccrC genes in a type V (5C2&5) staphylococcal cassette chromosome mec (SCCmec) of Staphylococcus aureus ST398 leads to conversion from methicillin resistance to methicillin susceptibility in vivo. Antimicrob Agents Chemother. 2010;54:783-791.
46. Wielders CL, Vriens MR, Brisse S, et al. In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet. 2001;357:1674-1675.
47. Jansen WT, Beitsma MM, Koeman CJ, et al. Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus. Antimicrob Agents Chemother. 2006;50:2072-2078.
48. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99:7687-7692.